Hikma Receives FDA Approval For TYZAVAN In The US
July 2, 2025
Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment Hikma Pharmaceuticals, the multinational pharmaceutical company, announced the approval of a novel formulation of the first-of-its-kind,